
Voilà ce qu’a dit Albert Bourla sur les vaccins ARNm au Washington Post :
“It was counterintuitive because Pfizer was mastering or let’s say we had very good experience and expertise with multiple technologies that could give a vaccine…mRNA was the technology that we had less experience with, only two years working on this. And actually, MRNA was a technology that never delivered a single product until that day. Not vaccine, not any other medicine, so it was very counterintuitive.”- Albert Bourla
Albert Bourla on why mRNA technology was "counterintuitive" to producing an effective vaccine
Washington Post - March 10, 2022 | 11:25 PM
Ajouter une réaction
Pour réagir, identifiez-vous avec votre login / mot de passe